Unknown

Dataset Information

Circulating Neoplastic-Immune Hybrid Cells Predict Metastatic Progression in Uveal Melanoma.


ABSTRACT:

Background

Uveal melanoma is an aggressive cancer with high metastatic risk. Recently, we identified a circulating cancer cell population that co-expresses neoplastic and leukocyte antigens, termed circulating hybrid cells (CHCs). In other cancers, CHCs are more numerous and better predict oncologic outcomes compared to circulating tumor cells (CTCs). We sought to investigate the potential of CHCs as a prognostic biomarker in uveal melanoma.

Methods

We isolated peripheral blood monocular cells from uveal melanoma patients at the time of primary treatment and used antibodies against leukocyte and melanoma markers to identify and enumerate CHCs and CTCs by immunocytochemistry.

Results

Using a multi-marker approach to capture the heterogeneous disseminated tumor cell pop

SUBMITTER: Parappilly MS 

PROVIDER: S-EPMC9564048 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature